Computer-assisted drug design.
Hopfinger
A J
AJ
D000806:Angiotensin-Converting Enzyme Inhibitors; D000903:Antibiotics, Antineoplastic; D002621:Chemistry / Q000379:methods*; D003201:Computers; D004247:DNA / Q000378:metabolism; D004345:Drug Industry; D005493:Folic Acid Antagonists; D008958:Models, Molecular; D008968:Molecular Conformation; D009268:Nalidixic Acid / Q000031:analogs & derivatives; D009279:Naphthacenes / Q000378:metabolism; D009643:Norfloxacin; D010330:Patents as Topic; D011955:Receptors, Drug / Q000378:metabolism; D013329:Structure-Activity Relationship; D013678:Technology, Pharmaceutical / Q000592:standards / Q000639:trends
D000806:Angiotensin-Converting Enzyme Inhibitors; D000903:Antibiotics, Antineoplastic; D005493:Folic Acid Antagonists; D009279:Naphthacenes; D011955:Receptors, Drug; D009268:Nalidixic Acid; D004247:DNA; D009643:Norfloxacin